1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsIntergenerational Wisdom Exchange Program is sponsored by RRF Foundation for Aging. The RRF Foundation for Aging supports programs that aim to develop intergenerational connections. A 2025 grant example supported an Intergenerational Wisdom Exchange Program for socially isolated Black and Hispanic older adults and college students of diverse backgrounds.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofit organizations focusing on older adults. Specifics on the 2026 program eligibility should be confirmed with the funder. Confirm the full requirements in the official notice before applying.
The current listing shows not specified (a two-year grant was noted in 2025). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Intergenerational Wisdom Exchange Program is funded by RRF Foundation for Aging. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article